Mentaily Raises $3M in Seed Funding to Transform Psychiatric Intervention Through AI-Powered Diagnosis and Support
GenAI Platform LIV Delivers Personal and Accurate Mental Health Response, Expanding the Pipeline of Pioneering Technologies from ARC at Sheba Medical Center
RAMAT GAN, ISRAEL, May 12, 2025 /EINPresswire.com/ -- Mentaily, the creator of AI-powered tools for mental health assessment, triage, and diagnosis of mental disorders, announced today the closing of a $3 million seed funding round. The round was led by a US-based family office and Israeli family offices, with participation from impact funds The Rashi Foundation and Sheatufim, and prominent digital health angel investors.Founded in 2024, Mentaily aims to address complex mental health needs emerging in times of crisis and trauma. The company’s first AI-powered product, LIV, simulates clinical psychiatric intake sessions and helps diagnosis psychological distress and mental illness, with high accuracy.
Mental health conditions are on the rise globally, yet support remains limited. In the United States alone, an estimated one in five people are affected by mental health issues, while over 120 million Americans live in areas with inadequate mental health services, highlighting the urgent need for new technologies to augment existing mental health interventions.
The AI platform supports multilingual, natural-language conversations through voice or text, optionally featuring AI avatar to deliver a personalized and scalable approach to mental health triage. The technology was created as a joint effort between ARC (Accelerate, Redesign, Collaborate) Innovation Center and the Drora and Pinchas Zakai Department of Psychiatry at Sheba Medical Center, along with Microsoft and KPMG.
In addition to serving the general population, LIV supports security forces through collaborations with the Directorate of Defense Research & Development (DDR&D) and Israel’s Ministry of Defense—addressing the needs of a population often affected by high stress and prolonged trauma. Future versions of the platform will be customized for additional populations, including children, adolescents, and women.
Already in use across hospitals, HMOs, rehabilitation centers, and government organizations across Israel, the new funding will support ongoing development and drive expansion both locally and into select international markets. Mentaily was founded by Iris Shtein, who serves as the company’s CEO, Guy Yachin, a serial Israeli-American entrepreneur, and senior clinicians from Sheba Medical Center: Prof. Mark Weiser, Dr. Asaf Caspi, and Dr. Daniel Cohen. The company is actively recruiting to support its expansion.
“At Mentaily, our mission goes beyond innovation—it’s about solving real-world challenges in mental health care,” said Iris Shtein, CEO and Co-Founder of Mentaily. “LIV enables real-time detection of deterioration and high-risk situations, allowing clinical teams to intervene early, with precision. By supporting clinical decision-making and optimizing workforce allocation, we help address the global shortage of mental health professionals. Our scalable platform not only enhances access and accuracy, but also empowers systems to prioritize care where it’s needed most, transforming psychiatric triage at a national and global level.”
“LIV is a prime example of innovation born from clinicians on the ground, developed through collaboration with additional players in the ecosystem: developers, international tech leaders, and business strategists,” said Prof Eyal Zimlichman, Founder and Director of ARC, Chief Transformation and Chief AI Officer at Sheba Medical Center. “LIV’s ability to identify, prioritize, and assess mental health conditions with accuracy and empathy makes it a promising tool for health systems worldwide. Another successful digital health platform in our growing portfolio, the solution is well aligned with ARC’s multi-faceted approach of responsibly and effectively developing and integrating AI into workflows of health systems globally.”
About Mentaily
Mentaily was founded in 2024 by Iris Shtein (CEO), Guy Yachin, Prof. Mark Weiser, Dr. Asaf Caspi, and Dr. Daniel Cohen, with a mission to improve access to mental health services through technology that enables an accessible, personalized, and empathetic diagnostic process.
The company was created out of world-renowned Sheba Medical Center with the belief that addressing Israel’s mental health crisis, particularly in regions affected by trauma, can create a model for other countries. The name LIV symbolizes life, resilience, and recovery, in response to the aftermath of the October 7th attacks. Mentaily’s approach combines personalized medicine, advanced technology, and sensitivity, with the goal of delivering an empathetic solution that is accessible worldwide.
About ARC
ARC (Accelerate, Redesign, Collaborate), the innovation arm of Sheba Medical Center, founded and directed by Prof. Eyal Zimlichman, is shaping the future of medical innovation by connecting entrepreneurs and clinicians, advancing the development and implementation of new technologies, and creating breakthrough economic frameworks in healthcare. ARC’s unique model—the first of its kind in global healthcare—has positioned evolved into a global blueprint, with a network of innovation centers in leading hospitals and research institutions across London, Melbourne, Singapore, Berlin, and New Zealand. ARC’s global network promotes technology-based medical solutions and accelerates the adoption of innovation within health systems worldwide.
ARC provides startups and researchers with exclusive access to Sheba’s core assets, clinical data and medical talent, while advancing the hospital’s vision to serve as a global hub for AI-driven medicine. The model’s success has already led to exits totaling approximately $1 billion, with profits reinvested to further accelerate Sheba’s AI and data revolution.
About Sheba Medical Center
The largest and most comprehensive medical center in the Middle East, Sheba Medical Center, Tel Hashomer is generating global impact through its medical care, research and AI-based healthcare transformation. Sheba’s City of Health boasts acute-care, rehabilitation, children’s, cancer and geriatric hospitals, research and innovation hubs, medical simulation center, center for disaster response and a virtual hospital on one comprehensive campus in the center of Israel. Sheba serves as a true hospital without borders, welcoming patients and healthcare professionals from all over the world and consistently providing the highest-level medical care to all in need. For more information, visit: https://sheba-global.com
Aviva Sapir
Number 10 Strategies
aviva@number10strategies.com
Visit us on social media:
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Synthetic Biology Market to Hit USD 84.7 Billion by 2035, Fueled by Advances in Gene Editing and Bio-Manufacturing
Zealmax Ortho at Pharmatech & Health, East Africa 2025, August 21-23, 2025
Metro East’s ISA Certified Arborists Offer 24/7 Emergency Tree Services to Protect Homes and Businesses
Więcej ważnych informacji
Jedynka Newserii

Jedynka Newserii

Farmacja

Nowy pakiet farmaceutyczny ma wyrównać szanse pacjentów w całej Unii. W Polsce na niektóre leki czeka się ponad dwa lata dłużej niż w Niemczech
Jeszcze pod przewodnictwem Polski Rada UE uzgodniła stanowisko w sprawie pakietu farmaceutycznego – największej reformy prawa lekowego od 20 lat. Ma on skrócić różnice w dostępie do terapii między krajami członkowskimi, które dziś sięgają nawet dwóch–trzech lat. W Unii Europejskiej wciąż brakuje terapii na ponad 6 tys. chorób rzadkich, a niedobory obejmują również leki ratujące życie. Nowe przepisy mają zapewnić szybszy dostęp do leków, wzmocnić konkurencyjność branży oraz zabezpieczyć dostawy.
Handel
Wzrost wydobycia ropy naftowej nie wpłynie na spadek cen surowca. Kierowcy jesienią zapłacą więcej za olej napędowy

Sierpień jest trzecim z rzędu miesiącem, gdy osiem krajów OPEC+ zwiększa podaż ropy naftowej na globalnym rynku; we wrześniu nastąpi kolejna zwyżka. Kraje OPEC, zwłaszcza Arabia Saudyjska, chcą w ten sposób odzyskać udziały w rynku utracone na skutek zmniejszenia wydobycia od 2022 roku, głównie na rzecz amerykańskich producentów. Nie należy się jednak spodziewać spadku cen ropy, gdyż popyt powinien być wysoki, a pod znakiem zapytania stoi dostępność ropy z Rosji. Nie zmienia to faktu, że jesienią ceny paliw na stacjach zazwyczaj rosną, a w największym stopniu podwyżki dotyczyć będą diesla.
Nauka
Szacowanie rzeczywistej liczby użytkowników miast dużym wyzwaniem. Statystycy wykorzystują dane z nowoczesnych źródeł

Różnica między liczbą rezydentów a rzeczywistą liczbą osób codziennie przebywających w Warszawie może sięgać nawet niemal pół miliona. Rozbieżności są dostrzegalne przede wszystkim w dużych miastach i ich obszarach funkcjonalnych. Precyzyjne dane populacyjne są tymczasem niezbędne w kształtowaniu usług społecznych i zdrowotnych, edukacyjnych, opiekuńczych, a także w planowaniu inwestycji infrastrukturalnych. W statystyce coraz częściej dane z oficjalnych źródeł, takich jak Zakład Ubezpieczeń Społecznych, są uzupełniane o te pochodzące od operatorów sieci komórkowych czy kart płatniczych.
Partner serwisu
Szkolenia

Akademia Newserii
Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.